The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global artificial cornea and corneal implant market was valued at US$ 385.5 Million in 2021.
We expect the global artificial cornea and corneal implant market to exhibit a CAGR of 7.10% during 2022-2027.
The rising cases of numerous ocular disorders, along with the growing consumer awareness towards artificial cornea and corneal implants in restoring vision, relieving pain, and treating damaged cornea, are currently catalyzing the global artificial cornea and corneal implant market.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective artificial cornea and corneal implant surgeries, to reduce the risk of coronavirus infection upon hospital visits or interaction with healthcare professionals or medical equipment.
Based on the type, the global artificial cornea and corneal implant market has been segmented into human cornea and artificial cornea, where human cornea holds the majority of the total market share.
Based on the transplant type, the global artificial cornea and corneal implant market can be divided into penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty, and keratoprosthesis. Currently, penetrating keratoplasty transplant exhibits a clear dominance in the market.
Based on the disease indication, the global artificial cornea and corneal implant market has been categorized into Fuchs' dystrophy, fungal keratitis, keratoconus, and others. Among these, Fuchs' dystrophy accounts for the majority of the global market share.
Based on the end user, the global artificial cornea and corneal implant market can be segregated into hospitals, ambulatory surgical centers, and specialty clinics. Currently, hospitals hold largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global artificial cornea and corneal implant market include Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC, and San Diego Eye Bank.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at